Global Viral Inactivation Market Research Report 2024(Status and Outlook)

Global Viral Inactivation Market Research Report 2024(Status and Outlook)



Report Overview:

Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.

The Global Viral Inactivation Market Size was estimated at USD 556.56 million in 2023 and is projected to reach USD 991.38 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.

This report provides a deep insight into the global Viral Inactivation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Inactivation Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Inactivation market in any manner.

Global Viral Inactivation Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Danaher

Merck

Parker Hannifin

Sartorius

SGS

Charles River Laboratories International

Clean Cells

Rad Source Technologies

Texcell

Viral Inactivated Plasma Systems

Wuxi Pharmatech (Cayman)

Market Segmentation (by Type)

Kits and Reagents

Services

Viral Inactivation Systems and Accessories

Market Segmentation (by Application)

Blood and Blood Products

Cellular and Gene Therapy Products

Stem Cell Products

Tissue and Tissue Products

Vaccines and Therapeutics

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Viral Inactivation Market
  • Overview of the regional outlook of the Viral Inactivation Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Inactivation Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Viral Inactivation
1.2 Key Market Segments
1.2.1 Viral Inactivation Segment by Type
1.2.2 Viral Inactivation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Viral Inactivation Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Viral Inactivation Market Competitive Landscape
3.1 Global Viral Inactivation Revenue Market Share by Company (2019-2024)
3.2 Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Viral Inactivation Market Size Sites, Area Served, Product Type
3.4 Viral Inactivation Market Competitive Situation and Trends
3.4.1 Viral Inactivation Market Concentration Rate
3.4.2 Global 5 and 10 Largest Viral Inactivation Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Viral Inactivation Value Chain Analysis
4.1 Viral Inactivation Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Viral Inactivation Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Viral Inactivation Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Inactivation Market Size Market Share by Type (2019-2024)
6.3 Global Viral Inactivation Market Size Growth Rate by Type (2019-2024)
7 Viral Inactivation Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Inactivation Market Size (M USD) by Application (2019-2024)
7.3 Global Viral Inactivation Market Size Growth Rate by Application (2019-2024)
8 Viral Inactivation Market Segmentation by Region
8.1 Global Viral Inactivation Market Size by Region
8.1.1 Global Viral Inactivation Market Size by Region
8.1.2 Global Viral Inactivation Market Size Market Share by Region
8.2 North America
8.2.1 North America Viral Inactivation Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Inactivation Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Inactivation Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Inactivation Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Inactivation Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Danaher
9.1.1 Danaher Viral Inactivation Basic Information
9.1.2 Danaher Viral Inactivation Product Overview
9.1.3 Danaher Viral Inactivation Product Market Performance
9.1.4 Danaher Viral Inactivation SWOT Analysis
9.1.5 Danaher Business Overview
9.1.6 Danaher Recent Developments
9.2 Merck
9.2.1 Merck Viral Inactivation Basic Information
9.2.2 Merck Viral Inactivation Product Overview
9.2.3 Merck Viral Inactivation Product Market Performance
9.2.4 Danaher Viral Inactivation SWOT Analysis
9.2.5 Merck Business Overview
9.2.6 Merck Recent Developments
9.3 Parker Hannifin
9.3.1 Parker Hannifin Viral Inactivation Basic Information
9.3.2 Parker Hannifin Viral Inactivation Product Overview
9.3.3 Parker Hannifin Viral Inactivation Product Market Performance
9.3.4 Danaher Viral Inactivation SWOT Analysis
9.3.5 Parker Hannifin Business Overview
9.3.6 Parker Hannifin Recent Developments
9.4 Sartorius
9.4.1 Sartorius Viral Inactivation Basic Information
9.4.2 Sartorius Viral Inactivation Product Overview
9.4.3 Sartorius Viral Inactivation Product Market Performance
9.4.4 Sartorius Business Overview
9.4.5 Sartorius Recent Developments
9.5 SGS
9.5.1 SGS Viral Inactivation Basic Information
9.5.2 SGS Viral Inactivation Product Overview
9.5.3 SGS Viral Inactivation Product Market Performance
9.5.4 SGS Business Overview
9.5.5 SGS Recent Developments
9.6 Charles River Laboratories International
9.6.1 Charles River Laboratories International Viral Inactivation Basic Information
9.6.2 Charles River Laboratories International Viral Inactivation Product Overview
9.6.3 Charles River Laboratories International Viral Inactivation Product Market Performance
9.6.4 Charles River Laboratories International Business Overview
9.6.5 Charles River Laboratories International Recent Developments
9.7 Clean Cells
9.7.1 Clean Cells Viral Inactivation Basic Information
9.7.2 Clean Cells Viral Inactivation Product Overview
9.7.3 Clean Cells Viral Inactivation Product Market Performance
9.7.4 Clean Cells Business Overview
9.7.5 Clean Cells Recent Developments
9.8 Rad Source Technologies
9.8.1 Rad Source Technologies Viral Inactivation Basic Information
9.8.2 Rad Source Technologies Viral Inactivation Product Overview
9.8.3 Rad Source Technologies Viral Inactivation Product Market Performance
9.8.4 Rad Source Technologies Business Overview
9.8.5 Rad Source Technologies Recent Developments
9.9 Texcell
9.9.1 Texcell Viral Inactivation Basic Information
9.9.2 Texcell Viral Inactivation Product Overview
9.9.3 Texcell Viral Inactivation Product Market Performance
9.9.4 Texcell Business Overview
9.9.5 Texcell Recent Developments
9.10 Viral Inactivated Plasma Systems
9.10.1 Viral Inactivated Plasma Systems Viral Inactivation Basic Information
9.10.2 Viral Inactivated Plasma Systems Viral Inactivation Product Overview
9.10.3 Viral Inactivated Plasma Systems Viral Inactivation Product Market Performance
9.10.4 Viral Inactivated Plasma Systems Business Overview
9.10.5 Viral Inactivated Plasma Systems Recent Developments
9.11 Wuxi Pharmatech (Cayman)
9.11.1 Wuxi Pharmatech (Cayman) Viral Inactivation Basic Information
9.11.2 Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
9.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Product Market Performance
9.11.4 Wuxi Pharmatech (Cayman) Business Overview
9.11.5 Wuxi Pharmatech (Cayman) Recent Developments
10 Viral Inactivation Regional Market Forecast
10.1 Global Viral Inactivation Market Size Forecast
10.2 Global Viral Inactivation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Inactivation Market Size Forecast by Country
10.2.3 Asia Pacific Viral Inactivation Market Size Forecast by Region
10.2.4 South America Viral Inactivation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Inactivation by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Viral Inactivation Market Forecast by Type (2025-2030)
11.2 Global Viral Inactivation Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings